Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

MGF Igf-1-ec

IGF-1Ec, IGF-1Eb, Mechano-Growth Factor

Quick Stats
Studies 62
Trials 100
Completed OBSERVATIONAL NCT02084095

IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

Background Glucose metabolism abnormalities are frequent in acromegaly. Insulin resistance (IR) correlates with the intensity of acromegaly and Insulin-like Growth factor-I (IGF-I) correlates better with IR than growth hormone (GH). Insulin secretion (IS) is significantly reduced in hyperglycemic acromegalics as compared with those with normal glucose levels. IS is independent of acromegaly intensity. The aim of this study is to show that in active acromegaly: 1) IGF-I does not cause IR but is just a better marker of acromegaly intensity than GH; 2) high GH levels induce IR through free fatty acids (FFA); 3) hyperglycemia is caused by a defficient IS on a background of IR. Methods Intensity of acromegaly will be assessed using serum levels of GH, IGF-I and IGF binding globulin-3. IR and IS will be assessd using an intravenous glucose tolerance test acording to Bergman model. FFA will be directly measured in plasma.

Primary Outcomes

Measure: The correlation coefficient between IGFBP-3 and insulin resistance assessed using Bergman model is non-inferior to the correlation coefficient between IGF-I and insulin resistance
TimeFrame: 2 years
Description:
Measure: Free fatty acids correlates significantly with insulin resistance assessed using Bergman model
TimeFrame: 2 years
Description:
Measure: Disposition index calculated using Bergman model is significantly reduced in subjects with glucose intolerance than in subjects with normal glucose tolerance
TimeFrame: 2 years
Description:

Trial Information

NCT ID

NCT02084095

Status

Completed

Study Type

OBSERVATIONAL

Sponsor

Carol Davila University of Medicine and Pharmacy

Last Updated

December 15, 2025